openPR Logo
Press release

Anti-Malarial Drug Market to Witness Significant Rise in Revenue During the Forecast Period 2023

01-15-2019 01:44 PM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Anti-Malarial Drug Market to Witness Significant Rise

Anti-malarial drugs are medications used for the treatment and prevention of malaria infection. They are also known as anti-malarials. These drugs are used for the routine intermittent treatment of specific groups in endemic regions. Anti-malarial drugs are also used for prevention of infection in individuals who travel or visit a malaria-endemic region. Efficacious antimalarial therapy not only reduces the morbidity and mortality of malaria but also reduces the risk of resistance to antimalarial drugs.

The global anti-malarial drugs market is gradually developing due to the surge in prevalence rate of malaria globally. Favorable government regulations, development of multi-drug resistance (MDR), an increase in research, development, and innovation in terms of anti-malaria therapeutics is anticipated to supplement market growth. However, possible side effects of anti-malaria drugs such as anxiety, dizziness insomnia, and others impede the growth of this market.

Download Sample Report with Detail TOC @ https://www.alliedmarketresearch.com/request-toc-and-sample/2760?utm_source=openpr&utm_medium=ss

Major Players:

•GlaxoSmithKline Plc
•Ranbaxy Laboratories
•Zydus Cadila
•Alvizia Health Care
•Bayer AG
•Pfizer Inc.
•Ipca Laboratories Ltd
•Merck KGaA
•F. Hoffmann-La Roche AG
•Novartis AG

Market Key Segments:

By Drug Type:

•Quinine
•Chloroquine
•Pyrimethamine
•Amodiaquine
•Proguanil
•Mefloquine
•Sulfonamide
•Artemisinin & Derivatives
•Atovaquone
•Primaquine
•Halofantrine
•Doxycycline
•Clindamycin

By Malaria Type:

•Plasmodium Falciparum
•Plasmodium Vivax
•Plasmodium Malariae
•Plasmodium Ovale

By Mechanism of Action:

•Resistance
•Prevention

By Distribution Channel

•Hospital Pharmacy
•Retail Pharmacy
•E-Commerce
•Others

Key Benefits:

• The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.

• It offers a quantitative analysis from 2017 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities.

• Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.

• Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

• Extensive analysis by product elucidates the use of anti-malarial drugs in medical settings.

Make an Enquiry on this Report @ https://www.alliedmarketresearch.com/purchase-enquiry/2760?utm_source=openpr&utm_medium=ss

About Us:
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti-Malarial Drug Market to Witness Significant Rise in Revenue During the Forecast Period 2023 here

News-ID: 1499423 • Views:

More Releases from Allied Market Research

Peanut Oil Market to garner $15,684.70 million by 2032, registering at a CAGR of 4.6%
Peanut Oil Market to garner $15,684.70 million by 2032, registering at a CAGR of …
Peanut oil market size was valued at $10,099.80 million in 2022 and is projected to reach $15,684.70 million by 2032, registering a CAGR of 4.6% from 2023 to 2032. As the cost of living continues to rise, consumer lifestyles are evolving leading to a noticeable trend toward hosting and dining at home rather than going out. This shift is playing a key role in increasing the demand for peanut oil. Peanut
Global Sandwich Panels Market to Generate $39.16 Billion by 2031: Dana Group, 3A …
According to the report published by Allied Market Research, the global sandwich panels market garnered $20.21 billion in 2021, and is estimated to generate $39.16 billion by 2031, manifesting a CAGR of 6.7% from 2022 to 2031. The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers a valuable guidance to leading players, investors, shareholders, and startups in
Brushless DC Motor Market to Reach $72.24 Billion by 2030, Growing at 8.1% CAGR …
Allied Market Research recently published a report, titled, "Brushless DC Motors Market by Rotor type (Inner Rotor, Outer Rotor), by Power range (0-750 W, 751 W- 3 KW, More Than 3 KW), by Speed (Less Than 500 RPM, 501 To 2000 RPM, 2001 To 10,000 RPM, More Than 10,000 RPM), by End user (Industrial Machinery, Automotive, Healthcare, HVAC Industry, Power tools, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030". As
Service Robotics Market to Reach $293.0 Billion, Globally, by 2032 at 24.3% CAGR …
Allied Market Research published a report, titled, "Service Robotics Market by Type (Professional Service Robotics, and Personal Service Robotics), and Application (Agriculture, Professional Cleaning, Inspection and Maintenance, Construction and Demolition, Transportation and Logistics, Medical, Search, Rescue, And Security, Hospitality, and Others): Global Opportunity Analysis and Industry Forecast, 2023-2032.". According to the report, the global service robotics industry generated $21.0 billion in 2020, and is anticipated to generate $293.0 billion by

All 5 Releases


More Releases for Malaria

Industry Dynamics of Cerebral Malaria Therapeutics
Global Cerebral Malaria Therapeutics Market: Overview Cerebral malaria, a severe neuropathological complication, primarily caused by Plasmodium falciparum. The infectious disease has become prevalent in tropical and sub-tropical countries. The cerebral malaria therapeutics market has evolved on the back of increased understanding of pathogenesis of the neurological syndrome. A growing array of biomarkers and tool in recent years have helped underpin the growing revenue potential in the market, giving rise to numerous
Malaria Vaccines – Paving the Way for a Malaria-free World
Recent Study on “Malaria Vaccines Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis and Forecast, 2018-2026” Added to Coherent Market Insights Reports Database. Malaria Vaccines Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Malaria Vaccines market research report is a professional
Malaria Disease Drug Pipeline Analysis
“Malaria Disease Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Malaria. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each drug
Rising Prevalence of Cerebral Malaria and Increasing Novel Drug Treatment Drives …
Malaria is a mosquito-borne infectious disease affecting humans and animals caused by parasitic protozoan belonging to the plasmodium family. Malaria is typically transmitted from human to human through the bite of an infected Anopheles (female) mosquito. Symptoms of malaria include fever, headache, fatigue, muscle pain, diarrhea, anemia, and vomiting. Severe malaria can cause yellow skin, seizures, coma, or death. Cerebral malaria is a form of severe malaria. Cerebral malaria has
03-08-2017 | Health & Medicine
TMR
Rising Prevalence of Cerebral Malaria and Increasing Novel Drug Treatment Drives …
Malaria is a mosquito-borne infectious disease affecting humans and animals caused by parasitic protozoan belonging to the plasmodium family. Malaria is typically transmitted from human to human through the bite of an infected Anopheles (female) mosquito. Symptoms of malaria include fever, headache, fatigue, muscle pain, diarrhea, anemia, and vomiting. Severe malaria can cause yellow skin, seizures, coma, or death. Cerebral malaria is a form of severe malaria. Cerebral malaria has
Malaria Diagnostics Market : Future Growth Potential Of The Malaria Diagnostic & …
Malaria is caused by the Plasmodium parasite, which is transmitted by the female Anopheles mosquito. As per the WHO, there were around 203 mn cases of malaria worldwide in 2012, resulting in approximately 627,000 deaths. The diagnosis of malaria involves detection with the help of blood tests and microscopy. Early and accurate diagnosis of malaria is vital for the rapid recovery of the patient and this has raised investments in